Heavy Menstrual Bleeding: Experiences and Learnings From Patient Survey
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026-06 · 66 (3)
DOI: 10.1111/ajo.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 11.05.2026. Verfasst von Mikaela Jacka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics & Gynaecology, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia. Hauptthemen laut MEDLINE: Menorrhagia, Patient Satisfaction. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Heavy menstrual bleeding (HMB) affects 1 in 4 women. It is often debilitating for those experiencing it, resulting in negative impacts on quality of life. Prompted by a national call for better insights into the management of HMB, the authors sought to collect patient feedback regarding access to HMB treatment alongside satisfaction with care, including treatment side effects, decision regret and the alignment of patient and clinician treatment goals.
Aims
This study aimed to gather patient feedback on the management of HMB treatment access, satisfaction, side effects, decision regret and alignment of patient and clinician treatment goals.
Methods
A retrospective recall survey was distributed to eligible participants at a single referral centre in regional Victoria, Australia. The survey was sent out to 1241 women who received treatment for heavy menstrual bleeding (HMB) between 01/01/2018 and 01/05/2023.
Results
There were 150 respondents to the survey, with 84% reporting a wait time of less than 2 months to see a clinician. Satisfaction with symptom control was reported by 96.9% of hysterectomy patients, while 9.3% reported intolerable side effects and 7.7% expressed regret. Symptom control was less effective for oral hormones (39.5%), non‐oral hormones (62.5%) and Mirena (48.4%), which also had higher rates of intolerable side effects (47.2%, 62.5% and 42%) and regret (18%, 41.7% and 27.4%).
Conclusion
The study underscores the need for personalised patient care in managing HMB, emphasising the importance of educating patients about treatment outcomes to support informed decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics & Gynaecology, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.
- OGB Surfcoast, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
- School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
- Obstetrics & Gynaecology Ballarat (OGB), School of Medicine, Deakin University, Wendouree, Victoria, Australia.
ORCID-Profile: Mikaela Jacka
Zitieren
APA
Jacka, M., Ward, M., Guerin, K., & Dalton, R. (2026). Heavy Menstrual Bleeding: Experiences and Learnings From Patient Survey. Australian and New Zealand Journal of Obstetrics and Gynaecology, 66(3). https://doi.org/10.1111/ajo.70143
Vancouver
Jacka M, Ward M, Guerin K, Dalton R. Heavy Menstrual Bleeding: Experiences and Learnings From Patient Survey. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026;66(3). doi:10.1111/ajo.70143
BibTeX
@article{Jacka2026,
author = {Jacka, Mikaela and Ward, Madeleine and Guerin, Katrina and Dalton, Russell},
title = {Heavy Menstrual Bleeding: Experiences and Learnings From Patient Survey},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2026},
volume = {66},
number = {3},
doi = {10.1111/ajo.70143}
}
EUVIMED